Gen.Orph Overview

  • Founded
  • 2012
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 1

Gen.Orph General Information


Producer of generic orphan drugs designed to treat rare diseases. The company's drugs aims at providing patients and medical teams worldwide with generic orphan drugs that are affordable and effective to cure rare diseases as well as drugs that are neglected by the pharmaceutical industry although they are still medically useful, enabling patients to get treatment at an affordable price

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 1 rue royale
  • 92210 Saint-Cloud
  • France
+33 01 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Gen.Orph Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 01-Jan-2014 Completed Generating Revenue
To view Gen.Orph’s complete valuation and funding history, request access »

Gen.Orph Executive Team (3)

Name Title Board Seat Contact Info
Etienne Jacob Chief Executive Officer & Co-Founder
Eric Lille Chief Financial Officer
Patrice Layrac Director & Co-Founder
To view Gen.Orph’s complete executive team members history, request access »

Gen.Orph Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Crédit Mutuel Innovation Venture Capital Minority 000 0000 000000 0
To view Gen.Orph’s complete investors history, request access »